Credit Agricole’s Soleno Therapeutics SLNO Stock Holding History

Credit Agricole’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17,500	Closed	-$586K	–	1386
2026 Q1	$586K	Buy	+17,500	New	+$686K	﹤0.01%	1165

Credit Agricole's SLNO Position: Q2 2026 in Review

Credit Agricole sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 17,500 shares — an estimated $586K sold.

Credit Agricole first reported a position in SLNO in Q1 2026 and held it in 1 quarter. The position peaked at $586K in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Credit Agricole reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Credit Agricole sold 17,500 Soleno Therapeutics shares in Q2 2026, an estimated $586K.
Credit Agricole first reported a position in Soleno Therapeutics in Q1 2026 and held it in 1 quarter.
Credit Agricole's Soleno Therapeutics position peaked at $586K in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.